Vericel Corporation Share Price

Vericel Corporation Share Price

NASDAQ: VCEL | Mid Cap
$57.90
+$0.43 (0.75%) Last updated on 18 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Vericel Corporation Stock Performance

Open
$57.46
Prev. Close
$57.47
Circuit Range
N/A
Day Range
$57.39 - $58.52
Year Range
$29.02 - $59.70
Volume
32,273
Average Traded
$57.95

Vericel Corporation Share Price Today

As of 18 November 2026, Vericel Corporation's share price is $57.90. The stock opened at $57.46, compared to its previous close of $57.47. During today's trading session, Vericel Corporation's share price traded between $57.39 and $58.52, with an average price of $57.95. Over the past 52 weeks, the stock has recorded a high of $59.70 and a low of $29.02. In terms of performance, Vericel Corporation's share price has risen by 73.87% over the last six months and is up 44.07% on a year-on-year basis.

Vericel Corporation Share Price Chart

Line chart of the Vericel Corporation price trend over the selected period. The price rose overall, ranging from 57.38 to 58.62, ending at 57.90.
$57.39$58.52
L
Show Current Price
H

Vericel Corporation Stock Fundamentals & Key Indicators

Market Cap
$2.91B
PE Ratio (TTM)
88.06
Dividend Yield
0.00%
EPS (TTM)
$0.65
Revenue (TTM)
$276.26B
Return On Equity (TTM)
8.67%
Profit Margin
5.98%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-39.07%

Vericel Corporation Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$92.92$68.43$77.46$85.37
Net Profit$23.24-$6.30$2.21$14.16
Net Profit Margin25.01%-9.21%2.85%16.59%
Income ChangeN/A-127.11%135.08%540.72%

Vericel Corporation Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$164.37$197.52$237.22$276.26
Net Profit-$16.71-$3.18$10.36$16.52
Net Profit Margin-10.17%-1.61%4.37%5.98%
Income ChangeN/A80.97%425.79%59.46%

About Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Vericel Corporation Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$40.44
$57.90
+43.99%
Oct 2026
$40.44
$40.21
+0.05%
Sep 2026
$39.66
$40.19
-2.38%
Aug 2026
$46.58
$41.17
-10.40%
Jul 2026
$44.76
$45.95
+3.30%
Jun 2026
$32.97
$44.48
+33.57%
May 2026
$34.65
$33.30
-4.20%
Apr 2026
$32.78
$34.76
+8.02%
Mar 2026
$34.92
$32.18
-9.44%
Feb 2026
$36.09
$35.53
-1.18%
Jan 2026
$35.96
$35.96
-0.11%
Dec 2025
$39.97
$36.00
-10.43%

VCEL Share Price FAQs